Tag: heart failure
Alleviant Medical secures funding for second pivotal trial of no-implant atrial shunt
Alleviant Medical has announced a US$90 million financing to fund its second pivotal trial.
The A...
TCT 2024: TAVI does not shift the dial in heart failure patients with moderate aortic stenosis
Transcatheter aortic valve implantation (TAVI) was no better than a conservative, surveillance s...
HFSA 2024: One-year data from PROACTIVE-HF show reduction in heart failure hospitalisation and all-cause mortality
Endotronix has announced the one-year clinical results from PROACTIVE-HF, evaluating outcomes fo...
RSA-pace study of Cysoni-XT temporary pacing system granted approval
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clini...
ACC 2024: Interatrial shunt fails to meet primary endpoint in RELIEVE-HF trial
Patients with heart failure who had an interatrial shunt inserted between the left and right atr...
Endotronix submits premarket approval application to US FDA for Cordella pulmonary artery sensor
Endotronix has submitted a premarket approval (PMA) application for its Cordella pulmonary arter...
Smart watches could predict higher risk of heart failure and arrhythmia
Wearable devices such as smart watches could be used to detect a higher risk of developing heart fai...
Remote monitoring improves survival in heart failure patients analysis finds
Abbott has today announced new data that found monitoring patients remotely with haemo...
BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system
BioVentrix, a privately held medical device company focused on the development of less invasive ther...
UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...
CVRx launches new version of neuromodulation device intended to treat heart failure
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodula...
Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure
Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indicat...
Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial
The placement of an interarterial shunt device—the Corvia atrial shunt (Corvia Medical)—did not ...
US physicians “among nation’s first” to implant neurostimulator technology for advanced heart failure
Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technol...
CardiAMP Heart Failure Trial continues with first patient randomised in Covid-19 era
BioCardia has announced that it has resumed cases in the CardiAMP Heart Failure Trial. The first...
Smartphone app uses can identify lung congestion in heart failure patients
Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing ...
ESC to stream the latest science in heart failure
The European Society of Cardiology (ESC) has announced that the HFA Discoveries online event will be...
Limited health literacy associated with a higher risk of death in heart failure patients
According to research published in JACC: Heart Failure, patients with heart failure who experien...
FDA Breakthrough Device Designation for novel heart failure therapy
VisCardia has been granted Breakthrough Device Designation from the US Food and Drug Administrat...
Soft robotic heart could be answer to donor heart shortage
A soft robotic heart that is designed to replace the need for a heart transplant is one of four ...
First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure sensor system
Endotronix has announced the enrollment of the first two patients in the PROACTIVE-HF trial. The...
Heart Research UK awards grant to University of Leeds to develop new heart failure treatments
A research project at the University of Leeds aiming to identify new drug treatments for heart f...
FDA approves new device to improve symptoms in patients with advanced heart failure
The US Food and Drug Administration has approved the Barostim Neo system for the improvement of ...
Novel wireless pressure monitoring system will have an “enormous impact” on HF patient care
Horst Sievert (Frankfurt, Germany) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France)...
New Australian research and development partnership aims to innovate heart failure care
Biotronik, the University of Newcastle (in Australia), and the John Hunter New England Local Health ...
First trial of in-heart micro device for left atrial pressure monitoring launched
Vectorious Medical Technologies has announced the initiation of the VECTOR-HF first-in-human (FI...
EACTS 2018: From bench to bedside: Roundtrip for cell therapy in heart disease
The study of stem cells in regenerative medicine is a growing field of basic and clinical resear...
HeartWare HVAD system receives US FDA approval
Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasi...
Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months
Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead o...
Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval
The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use...
Heart failure patient and clinician risk perceptions differ drastically
Physicians identified a majority of patients with advanced heart failure as at high risk for transpl...
EuroPCR 2017: Interventional management of acute heart failure—which device, when and how?
In this PCR video, filmed during EuroPCR (16–19 May, Paris, France), Atul Pathak (Clinique Pasteur, ...
Halting methamphetamine abuse can reverse related heart damage
Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve hea...
Non-O blood groups associated with higher risk of heart attack
Having a non-O blood group is associated with a higher risk of heart attack, according to research p...
ACC 2017: More hospitalisations & deaths for US heart failure patients in winter
Patients with heart failure in the USA are more likely to be hospitalised and more likely to die dur...
First patient treated with CardiAmp cell therapy for ischaemic heart failure in Phase III trial
Johns Hopkins Medicine, Baltimore, USA, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia h...
Increased physical activity, lower BMI may lower heart failure risk
While lifestyle patterns, including physical activity and body mass index (BMI), are associated with...
Cancer drug promotes regeneration of damaged heart tissue
An anticancer agent in development has been shown to promote regeneration of damaged heart muscl...
Northwestern Memorial Hospital ranked best in USA for heart attack, stroke and heart failure survival
Northwestern Memorial Hospital has been ranked best in the USA for survival of patients suffering he...
Latest statistics show heart failure on the rise
The number of adults living with heart failure increased from about 5.7 million (2009-2012) to a...
AHA 2016: Elizabeth M McNally wins AHA prize for research into genetic flaws responsible for inherited human disorders including heart failure
The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M Mc...
Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps
Abiomed has announced that its heart pumps Impella 2.5 and Impella 5.0 have received Pharmaceuti...
Berlin Heals announces closure of second round funding for cardiac microcurrent system
Berlin Heals has closed a second investment round in the run-up to the first-in-man application of i...
